CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT)CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT)CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT)

CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT)

No trades
See on Supercharts
Next report date
Report period
Q1 2024
EPS estimate
−1.09USD
Revenue estimate
Market capitalization
‪390.87 M‬USD
−10.4USD
‪−44.60 M‬USD
‪10.38 M‬
Beta (1Y)
0.87

About Corbus Pharmaceuticals Holdings, Inc.

CEO
Yuval Cohen
Headquarters
Norwood
Employees (FY)
19
Founded
2009
FIGI
BBG00LG7JS80
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its products include candidate, Lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded in April 2009 and is headquartered in Norwood, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 0SZI is featured.

Frequently Asked Questions

The current price of 0SZI is 37.6 USD — it has increased by 7.45% in the past 24 hours. Watch CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) stocks are traded under the ticker 0SZI.
CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
0SZI stock is 9.97% volatile and has beta coefficient of 0.87. Track CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) there?
0SZI earnings for the last quarter are −2.27 USD per share, whereas the estimation was −2.06 USD resulting in a −10.19% surprise. The estimated earnings for the next quarter are −2.16 USD per share. See more details about CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) earnings.
Yes, you can track CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
0SZI stock has risen by 0.71% compared to the previous week, the month change is a 7.07% rise, over the last year CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) has showed a 377.85% increase.
0SZI net income for the last quarter is ‪−8.02 M‬ USD, while the quarter before that showed ‪−10.05 M‬ USD of net income which accounts for 20.21% change. Track more CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) financial stats to get the full picture.
Today CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) has the market capitalization of ‪390.87 M‬, it has decreased by 8.32% over the last week.
No, 0SZI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0SZI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
0SZI reached its all-time high on Feb 19, 2019 with the price of 263.8 USD, and its all-time low was 2.2 USD and was reached on Mar 13, 2023. View more price dynamics on 0SZI chart.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has 19.00 employees. See our rating of the largest employees — is CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) stock shows the buy signal. See more of CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) future price: according to them, 0SZI price has a max estimate of 58.00 USD and a min estimate of 52.00 USD. Watch 0SZI chart and read a more detailed CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) stock forecast: see what analysts think of CORBUS PHARMACEUTICALS HOLDINGS IN COM USD0.0001(POST REV SPLIT) and suggest that you do with its stocks.